Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Moderna, Inc.
  6. News
  7. Summary
    MRNA   US60770K1079

MODERNA, INC.

(MRNA)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Relaxed Border Restrictions For U.S. Travelers Coming August 9, 2021

07/23/2021 | 02:10pm EDT

Key Points 

<ul
  • On July 19, 2021, the Public Health Agency of Canada announced several key changes to COVID-19 border restriction policies. These changes will lift many existing restrictions for fully vaccinated U.S. travelers.  
  • On August 9, 2021, at 12:01 a.m. EDT, fully vaccinated citizens and permanent residents of the United States (currently living in the U.S.) will be permitted to enter Canada for non-essential, discretionary travel. 
  • For U.S. travelers without full-vaccination status, and all other foreign nationals, Canadian borders remain closed. Exemptions remain in place for individuals meeting requirements laid out in the Quarantine Act
  • Overview 

    Eligible travelers must:  

    <ul
  • Be a fully vaccinated American citizen or permanent resident; and
  • Have received the complete series of a vaccine (or combination of vaccines) accepted by the Government of Canada at least 14 days prior to entering Canada:  
  • <ul
  • Acceptable vaccines are manufactured by Pfizer-BioNTech, Moderna, AstraZeneca/COVISHIELD, and Janssen (Johnson & Johnson); 
  • Travelers may receive their vaccine in any country;  
  • Travelers must present evidence supporting their vaccination in English, French or with a certified translation and the original. 
  • Additionally, fully vaccinated travelers must: 

    <ul
  • Submit all COVID-19-related information electronically through ArriveCAN, including proof of vaccination prior to departure for Canada (unless subject to exemption); 
  • Meet all pre-entry COVID-19 testing requirements; 
  • Be asymptomatic upon arrival to Canada; and, 
  • Possess a digital or paper version of vaccination documentation in French or English (or certified translation(s), along with the original). Government officials may ask to review them. 
  • Important Note about Children: 

    Unvaccinated children under 12 years of age, and unvaccinated dependent children (with certain mental or physical conditions) carrying U.S. citizenship or permanent residence and living in the U.S. may enter Canada with fully vaccinated parent(s), step-parent(s), tutor(s), grandparent(s), and/or guardian(s) meeting the same criteria. Children's information must be submitted electronically through ArriveCAN, and they must meet all testing requirements.  

    Finally, all travelers must still present a quarantine plan and prepare to fulfill it if border officers determine quarantine necessary. They will also be required to follow public health measures in place (i.e., masking in public places), for 14 days after entry in Canada. Air travelers must continue to mask in Canadian airports and on all flights to, from, and within Canada (regardless of vaccination status).  

    What are the Changes?  

    Beginning on August 9, 2021, the following changes will take effect: 

    New Testing Requirements 

    <ul
  • Canadian citizens and permanent residents travelling to the U.S. for less than 72 hours may complete their pre-entry test in Canada. 
  • Any individuals who have recovered from COVID-19, but continue to test positive, may present a positive COVID-19 molecular test result on a specimen taken 14 to 180 days before arrival in Canada. This will satisfy part of the pre-arrival test criteria. 
  • Post-arrival testing for fully vaccinated travelers has changed. Fully vaccinated travelers will not need a post-arrival test unless they are randomly selected to participate in the new border testing surveillance program. If randomly selected, travelers will complete a Day 1 COVID-19 molecular test. This program seeks to track new COVID-19 variants and vaccine effectiveness. 
  • Mandatory testing requirements remain in place for unvaccinated travelers. 
  • Lifting Temperature Screening Requirements 

    Effective August 9, 2021, Transport Canada will lift the requirement for the Canadian Air Transport Security Authority (CATSA) to collect pre-board temperature screenings. This change applies to passengers on all domestic flights and international departures (including Transborder). This also impacts airport workers. 

    Lifting Quarantine Requirements for Fully Vaccinated Travelers 

    Effective August 9, 2021, the Canadian government will eliminate the three-night government-authorized hotel stay requirement for air travelers. Mandatory quarantine requirements remain in place for unvaccinated travelers and unvaccinated children. Unvaccinated children may move around with their families, but they must avoid group settings for their first 14 days within Canada. Additional provincial rules may apply to unvaccinated children. 

    Eased Testing and Quarantine Requirements for Alternative Vaccination/Travel Situations 

    If travelers cannot be fully vaccinated due to a health condition, they may qualify for eased quarantine and testing requirements. These travelers will be required to follow a modified quarantine. More details will be released soon. 

    Travelers arriving in Canada by sea are now eligible for eased quarantine and testing requirements if they have received the complete series of a vaccine - or combination of vaccines - accepted by the Government of Canada at least 14 days prior to entering Canada (Pfizer-BioNTech, Moderna, AstraZeneca/COVISHIELD, and Janssen (Johnson & Johnson)). Sea travelers must meet all other criteria, including pre-entry test requirements and electronic information submission via ArriveCAN before or when entering Canada. All sea travelers must provide a quarantine plan and be prepared to fulfill it, in case border officials determine they do not qualify for exemption. 

    Looking Ahead 

    As vaccination rates continue to rise and COVID-19 case numbers decrease, it is possible that the Canadian Government will relax more restrictions in time. Employers with U.S.-based (citizens or permanent residence), Canada-bound talent should explore options to send individuals across the border later this summer. 

    Originally Published 21 July 2021

    The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

    Envoy Global, Inc.
    Envoy Global, Inc.
    230 W Monroe St
    Chicago
    UNITED STATES
    E-mail: insights@envoyglobal.com
    URL: www.envoyglobal.com/

    © Mondaq Ltd, 2021 - Tel. +44 (0)20 8544 8300 - http://www.mondaq.com, source Business Briefing

    Stocks mentioned in the article
    ChangeLast1st jan.
    ASTRAZENECA PLC -1.18% 8602 Delayed Quote.18.92%
    JOHNSON & JOHNSON -0.05% 164.43 Delayed Quote.4.54%
    MODERNA, INC. -0.85% 430.09 Delayed Quote.315.47%
    All news about MODERNA, INC.
    08:29aWHITE HOUSE REPORTEDLY URGED PFIZER : NY Times
    MT
    12:17aIndia Unlikely to Order Pfizer, Moderna COVID-19 Jabs As Local Vaccine Output Soars
    MT
    09/21MODERNA : Brazil and Argentina tapped to make mRNA vaccines in Latin America
    RE
    09/21MODERNA : U.S. administers 386.8 mln doses of COVID-19 vaccines - CDC
    RE
    09/21MODERNA : U.S. CDC Says Delivered 467,249,715 Doses Of Covid-19 Vaccine As Of Sept 21
    RE
    09/21Shangula Rages Against West's Vaccine Nationalism
    AQ
    09/21Johnson & Johnson Data Shows COVID-19 Booster Shots 94% Effective Against Moderate to S..
    MT
    09/21EUROPEAN MIDDAY BRIEFING : Stocks Rebound But -3-
    DJ
    09/21NORTH AMERICAN MORNING BRIEFING : Markets Steady -2-
    DJ
    09/20MODERNA : U.S. administers 386.2 mln doses of COVID-19 vaccines - CDC
    RE
    More news
    Analyst Recommendations on MODERNA, INC.
    More recommendations
    Financials (USD)
    Sales 2021 20 348 M - -
    Net income 2021 12 529 M - -
    Net cash 2021 12 947 M - -
    P/E ratio 2021 14,6x
    Yield 2021 -
    Capitalization 175 B 175 B -
    EV / Sales 2021 7,97x
    EV / Sales 2022 7,37x
    Nbr of Employees 1 300
    Free-Float 90,3%
    Chart MODERNA, INC.
    Duration : Period :
    Moderna, Inc. Technical Analysis Chart | MRNA | US60770K1079 | MarketScreener
    Technical analysis trends MODERNA, INC.
    Short TermMid-TermLong Term
    TrendsBullishBullishBullish
    Income Statement Evolution
    Consensus
    Sell
    Buy
    Mean consensus HOLD
    Number of Analysts 16
    Last Close Price 434,04 $
    Average target price 306,23 $
    Spread / Average Target -29,4%
    EPS Revisions
    Managers and Directors
    StÚphane Bancel Chief Executive Officer & Director
    Stephen Hoge President
    David W. Meline Chief Financial Officer
    Noubar B. Afeyan Chairman
    Juan Andres Chief Technical Operations & Quality Officer
    Sector and Competitors
    1st jan.Capi. (M$)
    MODERNA, INC.315.47%175 199
    LONZA GROUP AG33.09%60 866
    IQVIA HOLDINGS INC.43.03%49 103
    CELLTRION, INC.-23.26%31 708
    SEAGEN INC.-5.78%30 021
    PHARMARON BEIJING CO., LTD.83.56%25 723